Novo Nordisk and AWS Partner to Accelerate AI Drug Discovery
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Pune, India – May 5, 2026 Persistent Systems has partnered with the Indian Institute of Technology (IIT) Kharagpur to...
